http://www.frost.com/prod/servlet/svcg.pag/HCCD - Clinical Diagnostics Research en-us Market Engineering Research Service The aim of this research service is to thoroughly assess and analyse the in vitro diagnostics market in Western European countries and provide strategic recommendations and conclusions for the success of the market participants. This study gives an understanding of the key segments (Immunochemistry, Microbiology, Molecular Diagnostics, POCT, SMBG, Tissue Diagnostics, Hematology and Hemostasis), the likely future trends, revenue forecasts and competitive analysis of the Western European in vitro diagnostics market. This research also involves analysis of IVD market in the United Kingdom, Germany, France, Italy Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Denmark, Norway, Sweden, and Finland). http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M7C8-01-00-00-00 Mon, 30 Jan 2012 03:58:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M7C8-01-00-00-00 Market Engineering Research Service The primary objective of the study European Genetic Testing and Screening Services market is to assess the market potential of the current ongoing testing areas pertaining to the area of genetics such as diagnostic testing, relationship testing and predictive testing. Direct to consumer testing has received an immense attention and is creating the need to regulate the policies standards set for laboratories. Country wise predictions and their growth rates over the period 2010-2018 have been discussed for each segment. European regulations and the existing laws pertaining to genetic testing in the Western European countries have been discussed. A comprehensive list of 90 commercial test providers and manufacturers have been illustrated. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M7D9-01-00-00-00 Mon, 30 Jan 2012 01:25:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M7D9-01-00-00-00 Technical Insights Research Service Pharmacovigilance activities revolve around ensuring drug safety and preventing adverse drug reactions. While post marketing studies form the core of pharmacovigilance, inclusion of safety measures during clinical development and carrying out additional post marketing active surveillance is being utilized by a number of pharma companies. Risks due to supply and distribution of fake /spurious drugs is also on the rise with many anti -counterfeit solutions being developed. This research service delves into the technology trends in pharmacovigilance and anti-counterfeit technologies and also discusses some of the recent activities and developments from every segment of the industry. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E5-01-00-00-00 Thu, 19 Jan 2012 04:58:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E5-01-00-00-00 Decision Support Database Burden of Disease or Conditions Decision Support Database provides information on exhaustive list of Measurements on Incidence, Prevalence and Mortality for different types of Communicable and Non Communicable Disease. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD31-00-01-00-00 Mon, 16 Jan 2012 00:55:34 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD31-00-01-00-00 Technical Insights Alert This issue profiles harnessing cellular senescence pathway for cancer therapeutics, biomarker discovery and drug profiling empowered by label-free phosphoproteomics, and a drug composition as therapeutic/vaccine for obesity and atherosclerosis. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D950-00-3A-00-00 Fri, 13 Jan 2012 05:52:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D950-00-3A-00-00 Technical Insights Alert This issue profiles a microarray platform for orphan receptors and ligands, a ligosachharide-based test for diagnosis and prognosis of MPS, and an antibody generating platform based on somatic hypermutation. Strategic partnership details and some important patents have also been included. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7E-00-00 Fri, 13 Jan 2012 04:37:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7E-00-00 Technical Insights Alert This issue profiles drug delivery systems for regenerative medicine, an electron model for enhancing particle therapy for cancer, and a new sensor technology for detecting deterioration of telecommunication cables. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D705-00-6C-00-00 Fri, 13 Jan 2012 01:21:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D705-00-6C-00-00 Market Engineering Research Service This research study covers some of the key segments of the infectious diseases diagnostics market in western Europe. The main countries in the scope include the UK, France, Germany, Italy and Spain. The infectious disease segments that have been covered include MRSA, TB, HPV and emerging infections such as Hanta Virus and WNV. Wherever applicable, country-wise testing volumes information has been provided. Also revenue forecasts, unit shipments, market share analysis and competitive analysis has been provided. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M791-01-00-00-00 Sat, 31 Dec 2011 01:25:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M791-01-00-00-00 Technical Insights Research Service The nucleic acid drugs sector consists of three major sub-sectors--aptamer therapeutics, antisense therapeutics, and RNA interference. Recent partnerships and alliances show an amalgamation of collaborations for discovery platforms and delivery technologies as well as drug entities. This report analyzes the R&D portfolio trends in these sub-sectors and then uses the Analytical Hierarchy Process (AHP) to prioritize different options that can be executed to design a strategic R&D portfolio,which showcases a company's innovation capacity and also leads to higher credibility among investors. Portfolio options have been prioritized on a disease basis which is the one commonly followed by both big pharmaceuticals and biotech companies. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2C6-01-00-00-00 Fri, 30 Dec 2011 05:57:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2C6-01-00-00-00 Technical Insights Research Service The research service brings out the emerging technology trends in automated microbiology space on a global scale with focus on clinical and pharmaceutical microbiology needs. The report provides impact analysis of major drivers and restraints influencing the adoption of automated microbiology, with a detailed assessment of technology adoption levels and demand side analysis. Further, the report covers emerging opportunity evaluation, AHP based prioritization of techniques for rapid pathogen detection and strategic recommendations along with technology management strategies and roadmap. Finally, a list of key patents provide an insight into notable developmental activities receiving funding along with a database of global participants. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E4-01-00-00-00 Fri, 30 Dec 2011 00:37:48 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E4-01-00-00-00 Decision Support Database Healthcare Expenditure - Decision Support Database focuses on expenditure status of different countries across regions. This database presents fundamental healthcare indicators that aim to explain the wound management capabilities of nations. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD06-00-02-00-00 Thu, 29 Dec 2011 08:26:37 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD06-00-02-00-00 Market Engineering Research Service This research service provides an analysis of various aspects of the molecular diagnostics market in Europe for the years 2007 - 2015. The market has been divided into four segments: infectious diseases, genetic diseases, oncology and pharmacogenomics. The market has been covered segment wise, as well as geography wise, covering seven countries and regions. A detailed analysis of competitive landscape has been presented. The research service highlights main drivers and restraints for the market growth as well as key trends in the molecular diagnostics market for the period from 2011 to 2015. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M72C-01-00-00-00 Wed, 28 Dec 2011 04:40:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M72C-01-00-00-00 Market Engineering Research Service The primary objective of this study is to measure brand perceptions of tools and technologies currently at the forefront of stem cell research: bio-imaging and microscopy, cell biology tools, immunochemicals, molecular biology tools, and protein biochemistry tools. The study also looks into the usage pattern of these tools. An extensive end-user survey was conducted with 25 laboratories to assess the requirement and usage of tools. Insightful review of key industry drivers, restraints and challenges have been discussed. Leading market players and the prevailing competitive landscape for each of the segments have been discussed. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M72F-01-00-00-00 Tue, 27 Dec 2011 07:57:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M72F-01-00-00-00 Customer Research The editors of Lab Manager Magazine and Frost & Sullivan recently conducted a survey to better understand the sequencing end-user base. A total of 79 Lab Manager Magazine readers qualified for the survey as current or future users of sequencing technology, representing research and clinical laboratories, core facilities, sequencing services providers, and major genomes centers globally. This analysis investigates topics such as current and future adoption of sequencing technologies, brand and instrument preferences, outsourcing, laboratory budgets, sequencing utilization, applications, and challenges. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N952-01-00-00-00 Tue, 20 Dec 2011 10:35:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N952-01-00-00-00 Technical Insights Alert This issue profiles enhancing translational research in cancer through systems biology approaches, a placenta-derived stem cell therapy for a wide array of applications, and an adenoviral-based gene therapy for hemophilia B. Strategic partnership details and some important patents have also been included. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7B-00-00 Fri, 16 Dec 2011 06:29:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7B-00-00 Technical Insights Alert This issue profiles using an anti-telomerase therapy for drug-resistant mature or stem cancer cells, using carbohydrate mimetic peptide as an effective drug delivery vehicle, and using ellipticine compounds as anti-obesity small molecule therapeutics. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D950-00-39-00-00 Fri, 16 Dec 2011 05:28:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D950-00-39-00-00 Market Engineering Research Service This research service was carried out on three countries in East Africa; Kenya, Tanzania and Uganda. The research service focuses on analysing the market opportunity for testing and monitoring of five key diseases in this region; HIV, malaria, TB, HPV and diabetes. A brief healthcare overview of each country is provided in the research. Additionally, the research also provides an overview of laboratory services in each of the three countries. A seven-year forecast of the opportunity in the market for testing and monitoring the highlighted key diseases is also provided in the research service. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M732-01-00-00-00 Fri, 16 Dec 2011 02:42:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M732-01-00-00-00 Market Engineering Research This research segment presents findings from Frost & Sullivan's 2010 Voice-of-customer Project: a survey of 50 oncologists who work in physician office and hospital settings across the United States. The majority of oncologists surveyed believe that test vendors' marketing efforts were only somewhat effective or not effective at all. This result illuminates that more often than not, diagnostic companies miss the mark when targeting their key customer. Data was collected by a web-based survey and all respondents received an honorarium for participating. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=9837-00-21-00-00 Fri, 9 Dec 2011 04:57:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=9837-00-21-00-00